Fig. 4

Schematic representation of nanoparticles targeting ferroptosis and immunomodulation. Nanoparticles linked to effector molecules are delivered to tumor targets and simultaneously induce ferroptosis and immunogenetic cell death, thereby enabling ferroptosis-enhanced tumor immunotherapy, and stimulating long-term protective antitumor immune, acting as nano-vaccines